Literature DB >> 113079

Chronic myelomonocytic leukemia with paraproteinemia but no detectable plasmacytosis: a detailed cytological and immunological study.

D L Barnard, G F Burns, J Gordon, J C Cawley, C R Barker, F G Hayhoe, J L Smith.   

Abstract

A patient with chronic myelomonocytic leukemia with IgG K paraproteinemia, but no detectable plasmacytosis, is described. The patient was entering a blastic phase at the time of the most detailed studies. Cytological, cytochemical, and ultrastructural studies revealed a mixed myeloid proliferation with granulocytic forms predominating over monocytic elements. A variety of ultrastructural abnormalities, including defective granulation, was observed but no cells with highly developed rough endoplasmic reticulum were observed. Immunological marker studies showed that the mature myeloid cells possessed receptors for the Fc of IgG and weakly expressed the Ia-like P29/34 antigen. The mature myeloid cells also expressed both surface and intracytoplasmic Ig restricted to IgG K, and this IgG K persisted after 4 weeks in culture. A reverse plaque assay showed that the myeloid cells were capable of releasing IgG K in vitro, but studies involving the incorporation of radio-labeled amino acids showed no detectable Ig production by the myeloid cells. The possible interpretations of these data are discussed in some detail in relation to previous reports of paraproteinemia in myeloid proliferative disorders.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 113079     DOI: 10.1002/1097-0142(197909)44:3<927::aid-cncr2820440321>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Coincidence of primary myelodysplastic syndrome and non-Hodgkin lymphoma.

Authors:  R Schulze; G Schlimok; D Renner
Journal:  Clin Investig       Date:  1992-12

2.  Immunological abnormalities in myelodysplastic syndrome.

Authors:  B Seitanides; A Antonopoulou; A Karabelis
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

3.  Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: harm or benefit?

Authors:  Saloni Tanna; Celalettin Ustun
Journal:  Int J Hematol       Date:  2009-09-18       Impact factor: 2.490

Review 4.  Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.

Authors:  D M Layton; G J Mufti
Journal:  Blut       Date:  1986-12

5.  Immune abnormalities in myelodysplastic syndromes.

Authors:  T Economopoulos; J Economidou; G Giannopoulos; C Terzoglou; E Papageorgiou; J Dervenoulas; P Arseni; J Hadjioannou; S Raptis
Journal:  J Clin Pathol       Date:  1985-08       Impact factor: 3.411

6.  Changing biclonal gammopathy due to different lymphocyte clones in acquired immunodeficiency syndrome with Kaposi's sarcoma.

Authors:  H Piechowiak; R Hehlmann; J Abb; V Erfle; F D Goebel; M M Kochen; G Kreeb
Journal:  Klin Wochenschr       Date:  1985-10-15

7.  Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML).

Authors:  A N Stark; J Thorogood; C Head; B E Roberts; C S Scott
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.